Neurologic Abnormalities in HIV-1 Infected Children in the Era of Combination Antiretroviral Therapy

PLoS ONE

Volumn 8, Issue 5, 2013, Pages

  van Arnhem, Lotus A ^a   Bunders, Madeleine J ^a   Scherpbier, Henriette J ^a   Majoie, Charles B L M ^b   Reneman, Liesbeth ^b   Frinking, Olivier ^a   Poll The, Bwee Tien ^a   Kuijpers, Taco W ^a   Pajkrt, Dasja ^a  

^a EMMA CHILDREN S HOSPITAL   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ABACAVIR; ANTIRETROVIRUS AGENT; DIDANOSINE; EFAVIRENZ; INDINAVIR PLUS RITONAVIR; LAMIVUDINE; LOPINAVIR PLUS RITONAVIR; NELFINAVIR; NEVIRAPINE; STAVUDINE; ZIDOVUDINE;

ARTICLE; BLOOD LEVEL; BRAIN DISEASE; BRAIN SULCAL WIDENING; BRAIN VENTRICLE DILATATION; CD4 LYMPHOCYTE COUNT; CEREBROSPINAL FLUID LEVEL; CHILD; COHORT ANALYSIS; COMPUTER ASSISTED TOMOGRAPHY; DEVELOPMENTAL STAGE; DISEASE ASSOCIATION; FEMALE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; LANGUAGE DISABILITY; MAJOR CLINICAL STUDY; MALE; MUSCLE HYPERTONIA; MUSCLE HYPOTONIA; NETHERLANDS; NEUROIMAGING; NEUROLOGIC DISEASE; NEUROLOGIC EXAMINATION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OBSERVATIONAL STUDY; TREATMENT DURATION; VIRUS LOAD; WHITE MATTER LESION;

ANTI-HIV AGENTS; CHILD; DRUG THERAPY, COMBINATION; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; NERVOUS SYSTEM; TOMOGRAPHY, X-RAY COMPUTED; VIRAL LOAD;

EID: 84877760398     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0064398     Document Type: Article

References (26)

1. Joint United Nations Programme on HIV/AIDS (UNAIDS) and World Health Organization (WHO), AIDS epidemic update (2010) Available: http://www.unaids.org/globalreport/global_report.htm.Accessed 2010 Dec.
2. Epstein LG, Sharer LR, Oleske JM, Connor EM, Goudsmit J, et al. (1986) Neurologic manifestations of human immunodeficiency virus infection in children. Pediatrics 78: 678-687.
3. Cooper ER, Hanson C, Diaz C, Mendez H, Abboud R, et al. (1998) Encephalopathy and progression of human immunodeficiency virus disease in a cohort of children with perinatally acquired human immunodeficiency virus infection. J Pediatr 132: 808-812.
4. Epstein LG, Sharer LR, Joshi VV, Fojas MM, Koenigsberger MR, et al. (1985) Progressive encephalopathy in children with acquired immune deficiency syndrome. Ann Neurol 17: 488-496.
5. Schmitt B, Seeger J, Kreuz W, Enenkel S, Jacobi G, (1991) Central nervous system involvement of children with HIV infection. Dev Med Child Neurol 33: 535-540.
6. Angelini L, Zibordi F, Triulzi F, Cinque P, Giudici B, et al. (2000) Age-dependent neurologic manifestations of HIV infection in childhood. Neurol Sci 21: 135-142.
7. Chiriboga CA, Fleishman S, Champion S, Gaye-Robinson L, Abrams EJ, (2005) Incidence and prevalence of HIV encephalopathy in children with HIV infection receiving highly active anti-retroviral therapy (HAART). J Pediatr 146: 402-407.
8. Wilmshurst JM, Burgess J, Hartley P, Eley B, (2006) Specific neurologic complications of human immunodeficiency virus type 1 (HIV-1) infection in children. J Child Neuro. 21: 788-794.
9. Kieck JR, Andronikou S (.2004) Usefulness of neuro-imaging for the diagnosis of HIV encephalopathy in children. S Afr Med J 94: 628-630.
10. Visrutaratna P, Oranratanachai K, (2002) Clinics in diagnostic imaging (75). HIV encephalopathy and cerebral aneurysmal arteriopathy. Singapore Med J 43: 377-380.
11. Chamberlain MC, Nichols SL, Chase CH, (1991) Pediatric AIDS: comparative cranial MRI and CT scans. Pediatr Neurol 7: 357-362.
12. Johann-Liang R, Lin K, Cervia J, Stavola J, Noel G, (1998) Neuroimaging findings in children perinatally infected with the human immunodeficiency virus. Pediatr Infect Dis J 17: 753-754.
13. Patel K, Ming X, William PL, Robertson KR, Oleske JM, et al. (2009) Impact of HAART and CNS-penetrating antiretroviral regimens on HIV encephalopathy among perinatally infected children and adolescents. AIDS 23: 1893-1901.
14. Shanbhag MC, Rutstein RM, Zaoutis T, Zhao H, Chao D, et al. (2005) Neurocognitive functioning in pediatric human immunodeficiency virus infection. Arch Pediatr Adolesc Med 159: 651-656.
15. Raskino C, Pearson DA, Baker CJ, Lifschitz MH, O'Donnell K, et al. (1999) Neurologic, neurocognitive, and brain growth outcomes in human immunodeficiency virus-infected children receiving different nucleoside antiretroviral regimens. Pediatrics 104: 1-10.
16. Laughton B, Cornell M, Grove D, Kidd M, Springer PE, et al. (2012) Early antiretroviral therapy improves neurodevelopmental outcomes in infants. AIDS 26: 1685-1690.
17. Edén A, Fuchs D, Hagberg L, Nilsson S, Spudich S, et al. (2010) HIV-1 viral escape in cerebrospinal fluid of subjects on suppressive antiretroviral therapy. J Infect Dis 202: 1819-1825.
18. Scherpbier HJ, Bekker V, van Leth F, Jurriaans S, Lange JMA, et al. (2006) Long-term effectiveness with combination antiretroviral therapy that contains nelfinavir for up to 7 years in a pediatric cohort. Pediatrics 117: 528-536.
19. Scherpbier HJ, Bekker V, Pajkrt D, Jurriaans S, Lange JMA, et al. (2007) Once-daily highly active antiretroviral therapy for HIV-infected children: safety and efficacy of an efavirenz-containing regimen. Pediatrics 119: 707-715.
20. Johnson VA, Calvez V, Gunthard HF, Paredes R, Pillay D, et al. (2013) Update of the drug resistance mutations in HIV-1: March 2013. Top Antivir Med 21: 4-12.
21. Thao VP, Le T, Török EM, Yen NTB, Chau TTH, et al. (2012) HIV-1 drug resistance in antiretroviral-naive individuals with HIV-1-associated tuberculous meningitis initiating antiretroviral therapy in Vietnam. Antiviral Therapy 17: 905-913.
22. Sánchez-Ramón S, Resino S, Bellón Cano JM, Ramos JT, Gurbindo D, et al. (2003) Neuroprotective effects of early antiretrovirals in vertical HIV infection. Pediatr Neurol 29: 218-221.
23. Wood SM, Shah SS, Steenhoff AP, Rutstein RM, (2009) The impact of AIDS diagnoses on long-term neurocognitive and psychiatric outcomes of surviving adolescents with perinatally acquired HIV. AIDS 23: 1859-1865.
24. Violari A, Cotton MF, Gibb DM, Babiker AG, Steyn J, et al. (2008) Early antiretroviral therapy and mortality among HIV-infected infants. N Eng J Med 359: 2233-2244.
25. Letendre SL, Ellis RJ, Ances BM, McCutchan JA, (2010) Neurologic complications of HIV disease and their treatment. Trop HIV Med 18: 45-55.
26. Smurzynski M, Wu K, Letendre S, Robertson K, Bosch RJ, et al. (2011) Effects of central nervous system antiretroviral penetration on cognitive functioning in the ALLRT cohort. AIDS 25: 357-365.